A citation-based method for searching scientific literature

B N Atkinson, S C Bell, M De Vivo, L R Kowalski, S M Lechner, V I Ognyanov, C S Tham, C Tsai, J Jia, D Ashton, M A Klitenick. Mol Pharmacol 2001
Times Cited: 145







List of shared articles



Times cited

Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.
Stephen J Fairweather, Nishank Shah, Stefan Brӧer. Adv Exp Med Biol 2021
6

[18F]ALX5406: A Brain-Penetrating Prodrug for GlyT1-Specific PET Imaging.
Chris Hoffmann, Sibel Evcüman, Felix Neumaier, Boris D Zlatopolskiy, Swen Humpert, Dirk Bier, Marcus Holschbach, Annette Schulze, Heike Endepols, Bernd Neumaier. ACS Chem Neurosci 2021
0

Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset.
Imane Frouni, Sébastien Belliveau, Shawn Maddaford, Stephen G Nuara, Jim C Gourdon, Philippe Huot. Eur J Pharmacol 2021
0

A System for Assessing Dual Action Modulators of Glycine Transporters and Glycine Receptors.
Diba Sheipouri, Casey I Gallagher, Susan Shimmon, Tristan Rawling, Robert J Vandenberg. Biomolecules 2020
1

Glycine transporter-1 inhibitors: a patent review (2011-2016).
Christopher L Cioffi. Expert Opin Ther Pat 2018
5


Lipid inhibitors of high affinity glycine transporters: identification of a novel class of analgesics.
Jane E Carland, Cheryl A Handford, Renae M Ryan, Robert J Vandenberg. Neurochem Int 2014
12

Glycine transport inhibitors for the treatment of pain.
Robert J Vandenberg, Renae M Ryan, Jane E Carland, Wendy L Imlach, Macdonald J Christie. Trends Pharmacol Sci 2014
48

Oleoyl-L-carnitine inhibits glycine transport by GlyT2.
J E Carland, R E Mansfield, R M Ryan, R J Vandenberg. Br J Pharmacol 2013
21

Modulation of NMDA receptor function as a treatment for schizophrenia.
Christopher L Cioffi. Bioorg Med Chem Lett 2013
17

Interactions between glycine transporter type 1 (GlyT-1) and some inhibitor molecules - glycine transporter type 1 and its inhibitors (review).
Laszlo G Harsing, G Zsilla, P Matyus, K M Nagy, B Marko, Zs Gyarmati, J Timar. Acta Physiol Hung 2012
14




In vivo evaluation of carbon-11-labelled non-sarcosine-based glycine transporter 1 inhibitors in mice and conscious monkeys.
Jun Toyohara, Kiichi Ishiwata, Muneyuki Sakata, Jin Wu, Shingo Nishiyama, Hideo Tsukada, Kenji Hashimoto. Nucl Med Biol 2011
10

SLC6 neurotransmitter transporters: structure, function, and regulation.
Anders S Kristensen, Jacob Andersen, Trine N Jørgensen, Lena Sørensen, Jacob Eriksen, Claus J Loland, Kristian Strømgaard, Ulrik Gether. Pharmacol Rev 2011
478


An octahydro-cyclopenta[c]pyrrole series of inhibitors of the type 1 glycine transporter.
John A Lowe, Shari L Deninno, Susan E Drozda, Christopher J Schmidt, Karen M Ward, F David Tingley, Mark Sanner, Don Tunucci, James Valentine. Bioorg Med Chem Lett 2010
7

Recent progress in the discovery of non-sarcosine based GlyT1 inhibitors.
Scott E Wolkenberg, Cyrille Sur. Curr Top Med Chem 2010
29

Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test.
Mikhail Kalinichev, Kathryn R Starr, Simon Teague, Andrea M Bradford, Rod A Porter, Hugh J Herdon. Brain Res 2010
14

Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.
Karla Kopec, Dorothy G Flood, Maciej Gasior, Beth Ann W McKenna, Eva Zuvich, Justin Schreiber, Joseph M Salvino, John T Durkin, Mark A Ator, Michael J Marino. Biochem Pharmacol 2010
26

N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn.
Hyo-Jin Jeong, Robert J Vandenberg, Christopher W Vaughan. Br J Pharmacol 2010
41


Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors.
Zhijian Zhao, William H Leister, Julie A O'Brien, Wei Lemaire, David L Williams, Marlene A Jacobson, Cyrille Sur, Gene G Kinney, Doug J Pettibone, Philip R Tiller,[...]. Bioorg Med Chem Lett 2009
13

Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
Toshihiro Dohi, Katsuya Morita, Tomoya Kitayama, Naoyo Motoyama, Norimitsu Morioka. Pharmacol Ther 2009
76

The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter.
John A Lowe, Xinjun Hou, Christopher Schmidt, F David Tingley, Stan McHardy, Monica Kalman, Shari Deninno, Mark Sanner, Karen Ward, Lorraine Lebel,[...]. Bioorg Med Chem Lett 2009
27


Characteristics of glycine transport across the inner blood-retinal barrier.
Masashi Okamoto, Shin-ichi Akanuma, Masanori Tachikawa, Ken-ichi Hosoya. Neurochem Int 2009
15

The phosphatidylinositol 3-kinase inhibitor LY 294002 inhibits GlyT1-mediated glycine uptake.
Zhi-Liang Wu, Teresa M O'Kane, Thomas J Connors, Michael J Marino, Hervé Schaffhauser. Brain Res 2008
5

Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
Mario Mezler, Wilfried Hornberger, Reinhold Mueller, Martin Schmidt, Willi Amberg, Wilfried Braje, Michael Ochse, Hans Schoemaker, Berthold Behl. Mol Pharmacol 2008
46

Design of potent GlyT1 inhibitors: in vitro and in vivo profiles.
Thomas M Bridges, Richard Williams, Craig W Lindsley. Curr Opin Mol Ther 2008
38

Molecular basis for substrate discrimination by glycine transporters.
Robert J Vandenberg, Kim Shaddick, Pengchu Ju. J Biol Chem 2007
48


Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.
Robert W Buchanan, Robert Freedman, Daniel C Javitt, Anissa Abi-Dargham, Jeffrey A Lieberman. Schizophr Bull 2007
136